Fifth Lane Capital’s ZyVersa Therapeutics, Inc. Warrants ZVSAW Stock Holding History

Fifth Lane Capital’s Portfolio ZVSAW Stock Details ZVSAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-62,500	Closed	-$8K	–	252
2022 Q3	$8K	Buy	62,500 +25,000	+67%	+$3.23K	﹤0.01%	124
2022 Q2	$3K	Hold	37,500	–	–	﹤0.01%	315
2022 Q1	$6K	Buy	+37,500	New	+$7.59K	﹤0.01%	296

Fifth Lane Capital's ZVSAW Position: Q4 2022 in Review

Fifth Lane Capital sold out of ZyVersa Therapeutics, Inc. Warrants (ZVSAW) in Q4 2022, closing a stake of 62,500 shares — an estimated $8K sold.

Fifth Lane Capital first reported a position in ZVSAW in Q1 2022 and held it in 3 quarters. The position peaked at $8K in Q3 2022. 1 fund tracked by Wall St. Rank holds ZVSAW as of Q4 2022.

Fifth Lane Capital reported no remaining ZyVersa Therapeutics, Inc. Warrants position as of Q4 2022 after selling out during the quarter.
Fifth Lane Capital sold 62,500 ZyVersa Therapeutics, Inc. Warrants shares in Q4 2022, an estimated $8K.
Fifth Lane Capital first reported a position in ZyVersa Therapeutics, Inc. Warrants in Q1 2022 and held it in 3 quarters.
Fifth Lane Capital's ZyVersa Therapeutics, Inc. Warrants position peaked at $8K in Q3 2022.
1 fund tracked by Wall St. Rank held ZyVersa Therapeutics, Inc. Warrants as of Q4 2022.

Based on Fifth Lane Capital's 13F filing for Q4 2022, filed 14 Feb 2023.